Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 47 filings·Updated 13 Aug 2026
Showing 10 of 47 filings.
13 Aug 20261 filing
Company UpdateGeneral

Dhampur Bio Organics declares 15% final dividend for FY2025-26 and remits via NACH

Dividend declaration and remittance

  • Final dividend of ₹1.50 per share (15%) declared at AGM on 24 July 2026.
  • Record date fixed as 17.07.2026; payment by credit date 01.08.2026 via NACH.
  • TDS deducted on gross dividend above ₹10,000 as per Income Tax Act.
  • Shareholders may verify credit amount via bank statement; contact RTA for non-receipt.
  • RTA is Alankit Assignments Limited, New Delhi; remedies for non-receipt available.
  • Tax credit can be viewed in Form 26AS via TRACES or e-filing portal.
Filed 18:35View Source
10 Aug 20262 filings
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Promoter Sonitron Limited increases stake in Dhampur Bio Organics via two open-market acquisitions in Aug 2026

Transaction 1 — 05 Aug 2026 Open Market

  • Acquirer: Sonitron Limited (Promoter); 25,000 shares of Dhampur Bio Organics acquired Open Market on 05-08-2026.
  • Pre-hold: 1,14,80,499 shares (17.293%); post-hold: 1,15,05,499 shares (17.293%); equity capital: 6,63,87,590.

Transaction 2 — 06 Aug 2026 Open Market

  • Acquirer: Sonitron Limited (Promoter); 15,000 shares of Dhampur Bio Organics acquired Open Market on 06-08-2026.
  • Pre-hold: 1,15,05,499 shares (17.331%); post-hold: 1,15,20,499 shares (17.353%); equity capital: 6,63,87,590.
Filed 11:20View Source
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Sonitron Limited increases stake in Dhampur Bio Organics via open market purchases in Aug 2026

Transaction 1 (05 Aug 2026)

  • Target Company: Dhampur Bio Organics Limited.
  • Disclosing Party: Sonitron Limited, promoter group.
  • Transaction Type: Acquisition of 25,000 equity shares.
  • Pre-Transaction Holding: 1,14,80,499 shares, 17.293% voting rights.
  • Transaction Details: 25,000 shares acquired through Open Market.
  • Post-Transaction Holding: 1,15,05,499 shares, 17.293% voting rights.
  • Date of Transaction: 05.08.2026.
  • Equity share capital before/after: 6,63,87,590 shares.
  • Total diluted share capital: 6,63,87,590 shares.

Transaction 2 (06 Aug 2026)

  • Target Company: Dhampur Bio Organics Limited.
  • Disclosing Party: Sonitron Limited, promoter group.
  • Transaction Type: Acquisition of 15,000 equity shares.
  • Pre-Transaction Holding: 1,15,05,499 shares, 17.331% voting rights.
  • Transaction Details: 15,000 shares acquired through Open Market.
  • Post-Transaction Holding: 1,15,20,499 shares, 17.353% voting rights.
  • Date of Transaction: 06.08.2026.
  • Equity share capital before/after: 6,63,87,590 shares.
  • Total diluted share capital: 6,63,87,590 shares.
Filed 11:16View Source
31 Jul 20261 filing
Company UpdateChange in Management

Dhampur Bio Organics reports resignation of VP-Finance & Accounts effective July 31, 2026

Resignation of VP Finance & Accounts

  • Lalit Dalal, Vice President – Finance & Accounts, tendered resignation.
  • Resignation effective close of business hours on July 31, 2026.
  • Reason: to pursue career opportunities outside the organization.
  • Disclosure: Relationship with other directors not applicable.
Filed 18:28View Source
29 Jul 20261 filing
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Two open-market acquisitions by promoter Sonitron Limited in July 2026 increase Dhampur Bio Organics stake.

Open Market Acquisition — 24 Jul 2026

  • Target: Dhampur Bio Organics Limited; Acquirer: Sonitron Limited (promoter group).
  • Pre-holding: 1,14,71,231 shares (17.279%).
  • Acquired: 3,719 shares (0.006%), Open Market.
  • Post-holding: 1,14,74,950 shares (17.285%).
  • Date: 24.07.2026; Pre/post capital: 6,63,87,590 shares.
  • Total diluted capital: 6,63,87,590 shares.

Open Market Acquisition — 27 Jul 2026

  • Target: Dhampur Bio Organics Limited; Acquirer: Sonitron Limited (promoter group).
  • Pre-holding: 1,14,74,950 shares (17.285%).
  • Acquired: 5,549 shares (0.008%), Open Market.
  • Post-holding: 1,14,80,499 shares (17.293%).
  • Date: 27.07.2026; Capital before/after: 6,63,87,590 shares.
  • Total diluted capital: 6,63,87,590 shares.
Filed 10:08View Source
15 Jul 20262 filings
Company UpdateInvestor Presentation

Dhampur Bio Organics Q1 FY27: revenue up 4.5%, Meerganj sale completed, debt repaid, leverage improves

Business Overview

  • Integrated cane processor with Asmoli and Mansurpur plants serving sugar, biofuels, and country liquor.
  • Operations span three verticals: Sugar, Biofuels & Spirits, Country Liquor; IMIL focus.
  • Sale of Meerganj unit completed in June 2026; strategic shift to value-added offerings.

Operational Highlights

  • Q1 FY27 revenue rose 4.51% YoY to ₹553.88 crore.
  • PAT from continuing operations ₹-12.14 crore; Meerganj sale added ₹63.89 crore in discontinued operations.
  • Discontinued operations PAT includes ₹63.89 crore gain from Meerganj sale.
  • Meerganj unit sold on 18 June 2026.
  • Long-term loans repaid ₹93 crore in Q1 FY27.
  • Debt-to-equity ratio 0.18x as of 30 Jun 2026.
  • Revenue mix: Sugar ~78%, Biofuels & Spirits ~17%, Country Liquor ~5%.
  • Two integrated facilities with sugarcane capacity 20,500 TCD.
  • IMIL expansion: extended distillery capacity for Country Liquor production.

Financial Performance

  • Revenue (net of excise) for Q1 FY27: ₹553.88 crore; YoY +4.51%.
  • EBITDA ₹12.28 crore; margin 2.22%; including discontinued ₹12.40 crore.
  • PAT continuing ₹-12.14 crore; total PAT ₹38.40 crore including Meerganj gain.
  • Sugar revenue ₹392.31 crore; EBIT ₹4.73 crore; margin 1.21%.
  • Biofuel & Spirits revenue ₹80.78 crore; EBIT ₹6.60 crore; margin 8.17%.
  • Country Liquor revenue ₹103.41 crore; EBIT ₹3.45 crore; margin 3.34%.
  • Ethanol production 15.46 MN BL; ethanol sales 9.81 MN BL; avg realisation ₹60.96/BL.
  • Sugar sales 99,025 tons; avg realisation ₹42,403/ton.
  • Cane crushed total 20,500 TCD; power capacity 77 MW; renewable energy generation 8.24 Mn units.

Capital Structure & Liquidity

  • Long-term loans totaled ₹197 crore as of 30 Jun 2026.
  • Debt-to-equity ratio 0.18x as of 30 Jun 2026.
  • The company repaid ₹93 crore of long-term loans in Q1 FY27.
  • Meerganj sale proceeds aided balance sheet deleveraging.
  • Market cap ₹740.62 crore; free float 49.22%; shares outstanding 6.64 crore.
  • Credit rating: CARE BBB+; stable; short-term rating A2.

Strategic Priorities & Outlook

  • Focus on repositioning as value-added sugar and spirits and a bio-energy company.
  • Extended IMIL capacity to meet levy obligations; stronger integrated operations.
  • ESG framework with four pillars: Responsible Governance, Resource Efficient Operations, People First, Purposeful Products.
  • Certifications: ISO 9001:2015, ISO 14001:2015, FSSC 22000; Kosher/Halal; Bonsucro.
  • Sale of Meerganj unit supports deleveraging and strategic reallocation of capital.

Governance & Leadership

  • Board includes Chairman & CEO Gautam Goel; several independent directors.
  • Promoter stake 50.78%; free float 49.22% as of June 2026.
Filed 21:14View Source
Company UpdateNewspaper Publication

Pursuant to regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith the copies of Business Standard dated July 15, 2025, wherein the Unaudited financial results for the quarter ....

Filed 16:12View Source
14 Jul 20261 filing
Board MeetingOutcome of Board Meeting

Dhampur Bio Organics approves Q1 FY27 unaudited results; no interim dividend; internal auditor appointed; Meerganj sale completed

Financial results and major actions

  • Approved unaudited standalone and consolidated results for quarter ended June 30, 2026.
  • Board decided not to declare interim dividend.
  • Internal Auditor appointed for 2026-27: Grant Thornton Bharat LLP (appointment date July 14, 2026).
  • Discontinued Meerganj sugar unit sold; Rs 63.89 crore gain; EGM May 18, 2026 approval.
  • Independent auditor's limited review on standalone and consolidated results: unmodified conclusions.
Filed 12:40View Source
10 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

No physical shareholding reported under Regulation 74(5) certificate

Dematerialisation status

  • There is no holding of shares in physical form.
Filed 21:02View Source
9 Jul 20261 filing
Company UpdateAcquisition

Dhampur Bio Organics completes 74% acquisition of DBION Private Limited under JV with Orgonew

Target overview

  • Target: DBION Private Limited (formerly Sonitron Chemicals Private Limited) acquired 74% equity stake.
  • Acquisition price: Rs 74,000 for 7,400 shares of Rs 10 each.
  • Stake: 74% of paid-up equity share capital.
  • Under Joint Venture Agreement with Orgonew Private Limited.
  • DBION now a subsidiary of Dhampur Bio Organics and the JV company.
  • Industry/sector and country of presence not disclosed.
  • Strategic rationale: aligns and consolidates JV under the Dhampur-Orgonew alliance.
  • Regulatory approvals: not specified.
  • Timeline: completed as of July 9, 2026.
  • Related party status: not disclosed.
Filed 21:22View Source
Showing 10 of 47 filings